Dipanjan Chowdhury

Dana-Farber Cancer Institute

NIH Rank #9309
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.4M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#9,309
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.4M across 4 grants · National rank #9309.

Top grants by award amount

Dipanjan Chowdhury's NIH grant portfolio, ranked by award amount.

  • 1R01CA284565-01A1R01
    Enhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities
    $767K
    award amount
  • 5R01CA264900-03R01
    Elucidating the molecular mechanism and physiological relevance of TIRR mediated inhibition of p53
    $369.5K
    award amount
  • 1P01CA275717-01A1P01
    Regulation of BRCA-dependent Genome Repair via the 53BP1 Axis
    $204.4K
    award amount
  • 5U54CA274516-02U54
    Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
    $90.7K
    award amount

Affiliations

Institutions that have administered grants for Dipanjan Chowdhury.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #9309
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions